Biohaven (BHVN) Cash from Financing Activities (2021 - 2026)

Biohaven has disclosed Cash from Financing Activities across 6 years of filings, most recently posting $179.0 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $179.0 million, up 48413.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $617.8 million (down 8.44% YoY), and the FY2025 annual result was $439.1 million, down 35.21% from the prior year.
• Cash from Financing Activities came in at $179.0 million for Q1 2026 at Biohaven, down from $188.8 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $530.2 million in Q4 2022 to a low of -$39.7 million in Q3 2023.
• The 5-year median for Cash from Financing Activities is $86.8 million (2022), against an average of $133.8 million.
• Across the five-year window, Cash from Financing Activities tumbled 131.09% in 2023 and jumped 48413.82% in 2026, its largest moves.
• Biohaven's Cash from Financing Activities stood at $530.2 million in 2022, then sank by 53.74% to $245.2 million in 2023, then climbed by 11.26% to $272.9 million in 2024, then tumbled by 30.81% to $188.8 million in 2025, then retreated by 5.18% to $179.0 million in 2026.
• The last three Cash from Financing Activities figures came in at $179.0 million (Q1 2026), $188.8 million (Q4 2025), and $122000.0 (Q3 2025), per Business Quant data.